Holmusk

Singapore, Singapore Founded: 2015 • Age: 11 yrs Acquired By Twitter
AI-based digital health solutions and analytics are provided for providers.

About Holmusk

Holmusk is a company based in Singapore (Singapore) founded in 2015 by Nawal Roy was acquired by Twitter in July 2022. Holmusk has raised $109.29 million across 7 funding rounds from investors including Northwell, Veradigm and Heritas Capital Management. Holmusk has completed 1 acquisition, including MindLinc. Holmusk offers products and services including NeuroBlu Database, NeuroBlu Analytics, and Care Management Software. Holmusk operates in a competitive market with competitors including Neurosity, PREDICTIX, Televero Health, ThinkQuality and Mimerse, among others.

  • Headquarter Singapore, Singapore
  • Founders Nawal Roy
  • Sectors
    Healthcare
  • Website holmusk.com
  • Social LinkedIn X
  • Acquired by Twitter (Jul 2022)
  • Legal Name Kkt Technology Pte. Ltd.
Key Metrics
  • Annual Revenue
    $1.66 M (USD)
    73
    as on Mar 31, 2020
  • Net Profit
    -$2.8 M (USD)
    7
    as on Mar 31, 2020
  • EBITDA
    -$2.43 M (USD)
    7
    as on Mar 31, 2020
  • Total Equity Funding
    $109.29M (USD)

    in 7 rounds

  • Latest Funding Round
    $30M (USD), Series B

    Oct 2023

  • Investors
    Northwell

    & 6 more

  • Investments & Acquisitions
  • Acquired by
    Twitter

    (Jul 2022)

Products & Services of Holmusk

Holmusk offers a comprehensive portfolio of products and services, including NeuroBlu Database, NeuroBlu Analytics, and Care Management Software.

NeuroBlu Database
Data Platform

Offers real-world data for behavioral health studies and research.

NeuroBlu Analytics
Analytics Software

Provides tools for data analysis and cohort building in health research.

Care Management Software
Health Management

Utilizes data to enhance care operations and reduce costs effectively.

Funding Insights of Holmusk

Holmusk has successfully raised a total of $109.29M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $109.29M
  • Total Rounds 7
  • Last Round Series B β€” $30M
  • First Round $542,000

    (Jun 2016)

  • Investors Count 6

All 7 funding rounds of Holmusk with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2023$30MSeries B––
–
Jan 2023$45MSeries B–Veradigm
Dec 2021–Series A–dRx Capital, Northwell
May 2020$21.5MSeries A–Optum Ventures, Health Catalyst Capital
Sep 2018$9.75MSeed–Heritas Capital Management
–
Jun 2017$2.5MSeed––
–
Jun 2016$542,000Seed––
–
Valuation history

7 investors in total: 7 institutional.

Investors in Holmusk

Holmusk has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Northwell, Veradigm and Heritas Capital Management.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity and venture capital investment firm
–heritascapital.comSingapore, Singapore
Growth-stage US tech companies are funded by Health Catalyst Capital.
–healthcatalystcapital.comNew York, United States
Early-stage investments in US Tech and Life Sciences are targeted.
–drxcapital.comBasel, Switzerland
Early-stage tech and offline focused VC firm funding companies in the US
–optumventures.comBoston, United States
Cloud-based administrative suite solutions for healthcare organizations
1982veradigm.comChicago, United States
A chain of multispecialty hospitals is operated in New York.
1997northwell.eduNew York, United States
Social platform for microblogging
–twitter.comSan Francisco, United States
Premium access

Investor details for Holmusk

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Holmusk

33 people are tracked at Holmusk (15 in leadership, 8 in board & advisors, 10 in team).

NameRoleGroup
Nawal Roy
Founder & CEOLeadership
Paul Feldhausen
Chief of Staff & President, Head of HRLeadership
Sonali Luniya
VP, Corporate DevelopmentLeadership
Sai Subramanian
CTOLeadership
Nadia Lipunova
VP, Real-World EvidenceLeadership
Arnaud Fischer
Global Head, Growth Operations - RWE / RWD (nlp-enriched Clinical Data)Leadership
Subina Surendran
VP, Pharma & Life Sciences PartnershipsLeadership
Eileen Cheong Youne
Head, OperationsLeadership
Eze Abosi
Chief Growth OfficerLeadership
Wing Soon
Accounting & Finance DirectorLeadership
Leslie Way
Clinical Director I - Clinical DataLeadership
Léma Andrews-Hirano
Junior Chief Of Staff To Ceo/founderLeadership
Qian C.
Director, Data Engine OperationsLeadership
Amarnath D S
Director Of Product ManagementLeadership
Kevin Holland
Director Of Product Management, DataLeadership
Chik Wai Chiew
Board MemberBoard & advisors
Michael Weintraub
Chair of the BoardBoard & advisors
Charles Boorady
Board MemberBoard & advisors
Anand Tharmaratnam
Strategic AdvisorBoard & advisors
Vijay Barathan
Board MemberBoard & advisors

13 more people are available in the full profile.

Premium access

Complete people profiles for Holmusk

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Holmusk

Holmusk has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MindLinc.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
EMR platform and global database for behavioral health are offered.
mindlinc.comRaleigh, United States1997Jun 2016β€’β€’β€’β€’
Premium access

Complete acquisition details for Holmusk

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Holmusk

5 dated milestones of Holmusk across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Holmusk is founded.
  2. Funding First funding round of $542K.
  3. Acquisition Acquires MindLinc.
  4. Exit Acquired by Twitter.
  5. Funding Latest funding round, Series B, of $30.0M.

Competitors of Holmusk

Holmusk operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neurosity, PREDICTIX, Televero Health, ThinkQuality and Mimerse, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
neurosity.co2018Brooklyn, United States$4.98M1
Provider of neural devices and apps for mental health diagnosis and medical intervention
predictix.ai2015Tel Aviv, Israel––
Provider of AI-based mental health decision support platform
televerohealth.com2009Austin, United States$6.22M18
Cloud-based behavioral health therapy solution for providers
tqintelligence.com2016Atlanta, United States––
Clinical data intelligence is delivered with behavioral analysis for healthcare.
mimerse.com2014Stockholm, Sweden$825,280–
Develops innovative virtual reality applications for mental health treatments.
doctorpresso.com2022Seoul, South Korea––
AI-powered mental health solutions are provided globally.
opatus.se2013Pixbo, Sweden––
Neuropsychiatric assessment platform is provided for healthcare providers.
Premium access

Detailed competitors of Holmusk

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Holmusk

The website of Holmusk (holmusk.com) receives about 2.1K visits a month.

  • Monthly visits
    2.1K

    ▲ 37.1% vs previous month

Similar websites

Websites whose visitors overlap most with Holmusk. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
mobihealthnews.com
100%
133.6K#351,855View details

Latest news on Holmusk

Premium access

Complete news archive for Holmusk

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Holmusk

10 companies that operate in the same segment as Holmusk (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 713.57 M––
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M233
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M––
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 508.73 M––
App-based health insurance is offered to individuals and businesses.
2016Paris, FranceUSD 863.12 M––
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M–
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M––
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Holmusk

Holmusk was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Holmusk is headquartered in Singapore, Singapore.

Nawal Roy is the current CEO of Holmusk. They have also founded this company.

Holmusk is a funded company, having raised a total of $109.29M across 7 funding rounds to date. The company's 1st funding round was a Seed of $542K, raised on Jun 2016.

Annual revenue of Holmusk is $1.66M as on Mar 31, 2020.

AI-based digital health solutions and data analytics for providers. The platform NeuroBlu monitors the users data and the prediction engine recommends lifestyle changes before the condition worsens. The proprietary analytical tools work on real-world data to recognize disease progression. The EHR system is designed to capture and monitor decisions and is combined with past mental health records. It also enables data-driven research and development providing evidence for regulatory submission.

Holmusk's top competitors include Televero Health, Doctorpresso and Neurosity.

Holmusk offers NeuroBlu Database, NeuroBlu Analytics, and Care Management Software.

Holmusk has made 1 acquisition, including MindLinc.

Holmusk has 7 investors. Key investors include Northwell, Veradigm, Heritas Capital Management, Health Catalyst Capital, and dRx Capital.

Holmusk operates through Kkt Technology Pte. Ltd..

Yes. Holmusk was acquired by Twitter in July 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available